首页> 外文期刊>Biochimica et biophysica acta: international journal of biochemistry and biophysics >Crystallization and preliminary X-ray analysis of anti-cancer agent 3-(9-acridinylamino)-5-(hydroxymethyl)aniline complexed with the DNA hexamer d(CGTACG)(2).
【24h】

Crystallization and preliminary X-ray analysis of anti-cancer agent 3-(9-acridinylamino)-5-(hydroxymethyl)aniline complexed with the DNA hexamer d(CGTACG)(2).

机译:与DNA六聚体d(CGTACG)(2)络合的抗癌药3-(9-ac啶基氨基)-5-(羟甲基)苯胺的结晶和初步X射线分析。

获取原文
获取原文并翻译 | 示例
           

摘要

3-(9-Acridinylamino)-5-(hydroxymethyl)aniline (AHMA) is an anti-cancer agent with significant efficacy against murine leukemia and solid tumors. As a DNA topoisomerase inhibitor, AHMA is proposed to form a ternary complex with DNA and topoisomerase and bind to DNA in an intercalative manner. In order to understand the interactions between AHMA and DNA and study the structure-function relationship of amsacrine analogue, the AHMA-d(CGTACG)(2) complex was crystallized using the sitting-drop vapor-diffusion method. The native crystals diffract to 2.9-A resolution and belong to space group P3(1)21 or P3(2)21 with unit-cell parameters a=b=57.52, c=122.17 A when analyzed using Cu Kalpha radiation. Patterson map indicates that in the crystal, the directions of the DNA base stacking are nearly perpendicular to the c-axis of the crystal unit cell.
机译:3-(9-Acridinylamino)-5-(羟甲基)苯胺(AHMA)是一种抗癌药,对鼠类白血病和实体瘤具有显着疗效。作为DNA拓扑异构酶抑制剂,有人提出将AHMA与DNA和拓扑异构酶形成三元复合物,并以插入方式与DNA结合。为了了解AHMA与DNA的相互作用并研究amsacrine类似物的结构-功能关系,使用坐滴式蒸气扩散法将AHMA-d(CGTACG)(2)配合物结晶。当使用Cu Kalpha辐射分析时,天然晶体衍射到2.9-A分辨率,并且属于空间组P3(1)21或P3(2)21,其晶胞参数a = b = 57.52,c = 122.17A。帕特森图谱表明,在晶体中,DNA碱基堆叠的方向几乎垂直于晶体晶胞的c轴。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号